Postoperative Pulmonary Complications
Conditions
Brief summary
Postoperative pulmonary complications (PPCs) are a major cause of morbidity and mortality in surgical patients. National estimates suggest 1,062,000 PPCs per year, with 46,200 deaths, and 4.8 million additional days of hospitalization. The objective of the study is to develop and implement perioperative strategies to eliminate PPCs in abdominal surgery, the field with the largest absolute number of PPCs. We will conduct a randomized controlled pragmatic trial in 750 studied participants. The effectiveness of an individualized perioperative anesthesia-centered bundle will be compared to the usual anesthetic care in patients receiving open abdominal surgery. At the end of this project, the investigators expect to change clinical practice by establishing a new and clinically feasible anesthesia-centered strategy to reduce perioperative lung morbidity. The research will be conducted across 14 US academic centers, and will be funded by the National Institute of Health.
Detailed description
Postoperative pulmonary complications (PPCs) are a major cause of morbidity and mortality in surgical patients. National estimates suggest 1,062,000 PPCs per year, with 46,200 deaths, and 4.8 million additional days of hospitalization. Abdominal surgery is the field with the largest absolute number of PPCs. The long-term goal is to develop and implement perioperative strategies to eliminate PPCs. Whereas PPCs are as significant and lethal as cardiac complications, research in the field has received much less attention, and strategies to minimize PPCs are regrettably limited. Recently, the investigators and others have suggested a crucial role of anesthesia related interventions such as ventilatory strategies, and administration and reversal of neuromuscular blocking agents in reducing PPCs. These findings are consistent with the beneficial effects of lung protective ventilation during the adult respiratory distress syndrome (ARDS). While surgical patients differ substantially from ARDS patients as most have no or limited lung injury at the start of surgery, intraoperative anesthetic and abdominal surgery interventions result in lung derecruitment and predispose to or produce direct and indirect, potentially multiple-hit, lung injury. Thus, effective anesthetic strategies aiming at early lung protection in this group of patients are greatly needed. Indeed, the current lack of evidence results in wide and unexplained variability in anesthetic practices creating a major public health issue as some practices within usual care appear to be suboptimal and even potentially injurious. The investigators hypothesize that an anesthesia-centered bundle, based on recent findings and focused on perioperative lung protection, will minimize multiple and synergistic factors responsible for the multiple-hit perioperative pulmonary dysfunction and result in decreased incidence and severity of PPCs. Founded on strong preliminary data, we will leverage a network of US academic centers to study this hypothesis in two aims: Aim 1. To compare the number and severity of PPCs in participants receiving an individualized perioperative anesthesia-centered bundle to those in participants receiving usual anesthetic care during open abdominal surgery. For this, the investigators propose to conduct a prospective multicenter randomized controlled pragmatic trial with a blinded assessor in a total of 750 studied participants. The bundle will consist of optimal mechanical ventilation comprising individualized positive end-expiratory pressure to maximize respiratory system compliance and minimize driving pressures, individualized use of neuromuscular blocking agents and their reversal, and postoperative lung expansion and early mobilization; Aim 2. To assess the effect of the proposed bundle on plasma levels of lung injury biomarkers. The investigators theorize that our intervention will minimize overinflation and atelectasis reducing plasma levels of biomarkers of lung inflammatory, epithelial, and endothelial injury. Such mechanistic insights will facilitate bundle dissemination and support adoption as it has for lung protective ventilation for ARDS. At the end of this project, the investigators expect to change clinical practice by establishing a new and clinically feasible anesthesia-centered strategy to reduce perioperative lung morbidity.
Interventions
Brochure and video about relevance of postoperative pulmonary complications, postoperative mobilization and use of incentive spirometry.
PEEP will be set by maximizing respiratory system compliance along a decremental PEEP titration following an incremental recruitment maneuver.
Administration of neuromuscular blocking agents and their reversal will be done based on established protocol.
Participants will be encouraged to adhere to incentive spirometry to be started 2 hours after surgery and maintained until participant freely ambulates. Supervision will be provided 3 times/day for continuous education and management of barriers to optimal performance.
Participants will be encouraged to adhere to prescription of early ambulation.
Sponsors
Study design
Eligibility
Inclusion criteria
* Adults (\>=18 years) scheduled for elective surgery with expected duration \>=2 hours * Open abdominal surgery including: gastric, biliary, pancreatic, hepatic, major bowel, ovarian, renal tract, bladder, prostatic, radical hysterectomy, and pelvic exenteration * Intermediate or high risk of PPCs defined by an ARISCAT (Assess Respiratory Risk in Surgical Patients in Catalonia Score) risk score\>=26
Exclusion criteria
* Inability or refusal to provide consent * Inability or significant difficulty to perform any study interventions, including incentive spirometry, ambulation and/or maintaining follow-up contact with study personnel for up to 90 days after the date of surgery. * Participation in any interventional research study within 30 days of the time of the study. * Previous surgery within 30 days prior to this study. * Pregnancy * Emergency surgery * Severe obesity (above Class I, BMI\>=35 kg/m2) * Significant lung disease: any diagnosed or treated respiratory condition that (a) requires home oxygen therapy or non-invasive ventilation (except nocturnal treatment of sleep apnea without supplemental oxygen), (b) severely limits exercise tolerance to \<4 metabolic equivalents (METs) (e.g., patients unable to do light housework, walk flat at 4 miles/h or climb one flight of stairs), (c) required previous lung surgery, or (d) includes presence of severe pulmonary emphysema or bullae * Significant heart disease: cardiac conditions that limit exercise tolerance to \<4 METs * Renal failure: peritoneal or hemodialysis requirement or preoperative creatinine \>=2 mg/dL * Neuromuscular disease that impairs ability to ventilate without assistance * Severe chronic liver disease (Child-Turcotte-Pugh Score \>9, Appendix I) * Sepsis * Malignancy or other irreversible condition for which 6-month mortality is estimated \>=20% * Bone marrow transplant
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number and Severity of Postoperative Pulmonary Complications Between Participant Groups | Postoperative Days 0 through 7 | The distribution of the number and severity of accumulated post-operative pulmonary complications (PPCs) between the control and intervention groups during the first 7 days after surgery. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Number of Participants With Grade 3 and 4 Postoperative Pulmonary Complications | Postoperative Days 7, 30, and 90 | Individual grade 3 and 4 postoperative pulmonary complications within 7, 30, and 90 days after the day of the surgery. |
| Number of Participants With Hypoxemia by Postoperative Day 7 | Postoperative Days 0 through 7 | Presence of any hypoxemia (as defined in PPC grade 1 and 2) within 7 days after the day of the surgery. |
| Number of Participants With Atelectasis by Postoperative Day 7 | Days 0 through 7 after the day of surgery | Presence of atelectasis (radiological confirmation + either temperature \>37.5°C or abnormal lung symptoms/signs) by day 7 after the date of surgery. |
| Number of Participants With Pneumonia (Suspected and Proved) by Postoperative Day 7 | Days 0 through 7 | Incidence of suspected (radiological evidence without bacteriological confirmation) and proved (radiological evidence and documentation of pathological organism) pneumonia by day 7 after the date of surgery. |
| Number of Participants With Ventilatory Dependence or Failure by Postoperative Day 7 | Days 0 through 7 | Number of participants with ventilatory dependence (Grade 3, non-invasive or invasive ventilation \< 48h) or failure (Grade 4, postoperative non-invasive or invasive ventilation dependence ≥ 48h) by day 7 after the date of surgery. |
| Number of Participants With Grade 1 and 2 Postoperative Pulmonary Complications | Postoperative Days 0 through 7 | Individual grade 3 and 4 postoperative pulmonary complications within 7 days after the day of the surgery. |
| Number of Participants With Both Intraoperative Hypoxemia and Rescue Recruitment Maneuvers | Day 0 | The incidence of both intraoperative hypoxemia (SpO2 \< 85%) and rescue recruitment maneuvers during surgery. Received unplanned RM or PEEP titrations or adjustments during surgery for oxygenation or ventilation rescue. |
| Number of Participants With Intraoperative Cardiovascular Events | Day 0 | Number of participants with hypotension, bradycardia, tachycardia, arrhythmias, new ST-segment changes and cardiac arrest |
| Length of Hospital Stay | Days 0 through 7, 30, and 90 | Number of days the participant has spent in the hospital since the day of the surgery. |
| Number of Participants With Other Hospital Readmission(s) After Initial Discharge | After the date of discharge to day 90 | The number of participants with hospital readmission(s), other than to the Intensive Care Unit, if admitted. |
| Number of Participants With Any Major Extrapulmonary Complications | Days 0 to 7 | Number of participants with arrhythmia, paralytic ileus, surgical site infection, infection (source uncertain), acute renal failure, and systemic inflammatory response syndrome. |
| Length of Postoperative Oxygen Support | Up to 7 days post-surgery | Number of time (hours or days) spent in the postoperative oxygen therapy or other respiratory support |
Countries
United States
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| Usual Care Participants in this arm will receive usual anesthetic and postoperative care as provided in each site. | 372 |
| Intervention This arm will receive the bundle of perioperative interventions. | 379 |
| Total | 751 |
Withdrawals & dropouts
| Period | Reason | FG000 | FG001 |
|---|---|---|---|
| Overall Study | Consent Not Obtained for Other Reasons | 3 | 3 |
| Overall Study | Consent Withdrawn | 9 | 6 |
| Overall Study | Found Ineligible for Study | 4 | 3 |
| Overall Study | Intervention Not Done and No Data Collected | 0 | 1 |
| Overall Study | Surgery Cancelled | 4 | 4 |
| Overall Study | Verbal Agreement Withdrawn | 4 | 2 |
Baseline characteristics
| Characteristic | Usual Care | Intervention | Total |
|---|---|---|---|
| Age, Continuous | 62.4 years STANDARD_DEVIATION 12 | 61.1 years STANDARD_DEVIATION 13.5 | 61.7 years STANDARD_DEVIATION 12.8 |
| ARISCAT Total Score | 40.9 score on a scale STANDARD_DEVIATION 7.6 | 41.0 score on a scale STANDARD_DEVIATION 7.2 | 41.0 score on a scale STANDARD_DEVIATION 7.4 |
| Race (NIH/OMB) American Indian or Alaska Native | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Asian | 21 Participants | 14 Participants | 35 Participants |
| Race (NIH/OMB) Black or African American | 23 Participants | 21 Participants | 44 Participants |
| Race (NIH/OMB) More than one race | 7 Participants | 3 Participants | 10 Participants |
| Race (NIH/OMB) Native Hawaiian or Other Pacific Islander | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Unknown or Not Reported | 43 Participants | 47 Participants | 90 Participants |
| Race (NIH/OMB) White | 278 Participants | 294 Participants | 572 Participants |
| Sex: Female, Male Female | 190 Participants | 170 Participants | 360 Participants |
| Sex: Female, Male Male | 182 Participants | 209 Participants | 391 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | 5 / 396 | 6 / 398 |
| other Total, other adverse events | 19 / 396 | 36 / 398 |
| serious Total, serious adverse events | 35 / 396 | 35 / 398 |
Outcome results
Number and Severity of Postoperative Pulmonary Complications Between Participant Groups
The distribution of the number and severity of accumulated post-operative pulmonary complications (PPCs) between the control and intervention groups during the first 7 days after surgery.
Time frame: Postoperative Days 0 through 7
Population: Individual PPCs experienced by participants in both study arms.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| Usual Care | Number and Severity of Postoperative Pulmonary Complications Between Participant Groups | Grade 1 (mild) | 35 complications |
| Usual Care | Number and Severity of Postoperative Pulmonary Complications Between Participant Groups | Grade 3 (severe) | 27 complications |
| Usual Care | Number and Severity of Postoperative Pulmonary Complications Between Participant Groups | Grade 2 (moderate) | 225 complications |
| Usual Care | Number and Severity of Postoperative Pulmonary Complications Between Participant Groups | Gade 4 (ventilatory failure) | 1 complications |
| Usual Care | Number and Severity of Postoperative Pulmonary Complications Between Participant Groups | Grade 0 (none) | 84 complications |
| Intervention | Number and Severity of Postoperative Pulmonary Complications Between Participant Groups | Gade 4 (ventilatory failure) | 3 complications |
| Intervention | Number and Severity of Postoperative Pulmonary Complications Between Participant Groups | Grade 0 (none) | 73 complications |
| Intervention | Number and Severity of Postoperative Pulmonary Complications Between Participant Groups | Grade 1 (mild) | 51 complications |
| Intervention | Number and Severity of Postoperative Pulmonary Complications Between Participant Groups | Grade 2 (moderate) | 211 complications |
| Intervention | Number and Severity of Postoperative Pulmonary Complications Between Participant Groups | Grade 3 (severe) | 41 complications |
Length of Hospital Stay
Number of days the participant has spent in the hospital since the day of the surgery.
Time frame: Days 0 through 7, 30, and 90
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Usual Care | Length of Hospital Stay | 6.8 days | Standard Deviation 5.9 |
| Intervention | Length of Hospital Stay | 7.2 days | Standard Deviation 6.1 |
Length of Postoperative Oxygen Support
Number of time (hours or days) spent in the postoperative oxygen therapy or other respiratory support
Time frame: Up to 7 days post-surgery
| Arm | Measure | Value (MEDIAN) |
|---|---|---|
| Usual Care | Length of Postoperative Oxygen Support | 19.2 hours |
| Intervention | Length of Postoperative Oxygen Support | 14.6 hours |
Number of Participants With Any Major Extrapulmonary Complications
Number of participants with arrhythmia, paralytic ileus, surgical site infection, infection (source uncertain), acute renal failure, and systemic inflammatory response syndrome.
Time frame: Days 0 to 7
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| Usual Care | Number of Participants With Any Major Extrapulmonary Complications | 43 Participants |
| Intervention | Number of Participants With Any Major Extrapulmonary Complications | 48 Participants |
Number of Participants With Atelectasis by Postoperative Day 7
Presence of atelectasis (radiological confirmation + either temperature \>37.5°C or abnormal lung symptoms/signs) by day 7 after the date of surgery.
Time frame: Days 0 through 7 after the day of surgery
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| Usual Care | Number of Participants With Atelectasis by Postoperative Day 7 | 59 Participants |
| Intervention | Number of Participants With Atelectasis by Postoperative Day 7 | 70 Participants |
Number of Participants With Both Intraoperative Hypoxemia and Rescue Recruitment Maneuvers
The incidence of both intraoperative hypoxemia (SpO2 \< 85%) and rescue recruitment maneuvers during surgery. Received unplanned RM or PEEP titrations or adjustments during surgery for oxygenation or ventilation rescue.
Time frame: Day 0
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| Usual Care | Number of Participants With Both Intraoperative Hypoxemia and Rescue Recruitment Maneuvers | 21 Participants |
| Intervention | Number of Participants With Both Intraoperative Hypoxemia and Rescue Recruitment Maneuvers | 6 Participants |
Number of Participants With Grade 1 and 2 Postoperative Pulmonary Complications
Individual grade 3 and 4 postoperative pulmonary complications within 7 days after the day of the surgery.
Time frame: Postoperative Days 0 through 7
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| Usual Care | Number of Participants With Grade 1 and 2 Postoperative Pulmonary Complications | 260 Participants |
| Intervention | Number of Participants With Grade 1 and 2 Postoperative Pulmonary Complications | 262 Participants |
Number of Participants With Grade 3 and 4 Postoperative Pulmonary Complications
Individual grade 3 and 4 postoperative pulmonary complications within 7, 30, and 90 days after the day of the surgery.
Time frame: Postoperative Days 7, 30, and 90
| Arm | Measure | Group | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| Usual Care | Number of Participants With Grade 3 and 4 Postoperative Pulmonary Complications | Most Severe PPC Grade 3 or 4 by POD 7 | 28 Participants |
| Usual Care | Number of Participants With Grade 3 and 4 Postoperative Pulmonary Complications | Most Severe PPC Grade 3 or 4 by POD 30 | 32 Participants |
| Usual Care | Number of Participants With Grade 3 and 4 Postoperative Pulmonary Complications | Most Severe PPC Grade 3 or 4 by POD 90 | 35 Participants |
| Intervention | Number of Participants With Grade 3 and 4 Postoperative Pulmonary Complications | Most Severe PPC Grade 3 or 4 by POD 7 | 44 Participants |
| Intervention | Number of Participants With Grade 3 and 4 Postoperative Pulmonary Complications | Most Severe PPC Grade 3 or 4 by POD 30 | 49 Participants |
| Intervention | Number of Participants With Grade 3 and 4 Postoperative Pulmonary Complications | Most Severe PPC Grade 3 or 4 by POD 90 | 53 Participants |
Number of Participants With Hypoxemia by Postoperative Day 7
Presence of any hypoxemia (as defined in PPC grade 1 and 2) within 7 days after the day of the surgery.
Time frame: Postoperative Days 0 through 7
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| Usual Care | Number of Participants With Hypoxemia by Postoperative Day 7 | 263 Participants |
| Intervention | Number of Participants With Hypoxemia by Postoperative Day 7 | 284 Participants |
Number of Participants With Intraoperative Cardiovascular Events
Number of participants with hypotension, bradycardia, tachycardia, arrhythmias, new ST-segment changes and cardiac arrest
Time frame: Day 0
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| Usual Care | Number of Participants With Intraoperative Cardiovascular Events | 18 Participants |
| Intervention | Number of Participants With Intraoperative Cardiovascular Events | 21 Participants |
Number of Participants With Other Hospital Readmission(s) After Initial Discharge
The number of participants with hospital readmission(s), other than to the Intensive Care Unit, if admitted.
Time frame: After the date of discharge to day 90
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| Usual Care | Number of Participants With Other Hospital Readmission(s) After Initial Discharge | 0 Participants |
| Intervention | Number of Participants With Other Hospital Readmission(s) After Initial Discharge | 0 Participants |
Number of Participants With Pneumonia (Suspected and Proved) by Postoperative Day 7
Incidence of suspected (radiological evidence without bacteriological confirmation) and proved (radiological evidence and documentation of pathological organism) pneumonia by day 7 after the date of surgery.
Time frame: Days 0 through 7
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| Usual Care | Number of Participants With Pneumonia (Suspected and Proved) by Postoperative Day 7 | 18 Participants |
| Intervention | Number of Participants With Pneumonia (Suspected and Proved) by Postoperative Day 7 | 28 Participants |
Number of Participants With Ventilatory Dependence or Failure by Postoperative Day 7
Number of participants with ventilatory dependence (Grade 3, non-invasive or invasive ventilation \< 48h) or failure (Grade 4, postoperative non-invasive or invasive ventilation dependence ≥ 48h) by day 7 after the date of surgery.
Time frame: Days 0 through 7
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| Usual Care | Number of Participants With Ventilatory Dependence or Failure by Postoperative Day 7 | 15 Participants |
| Intervention | Number of Participants With Ventilatory Dependence or Failure by Postoperative Day 7 | 22 Participants |